ConductScience.org, home

Paper38533720

Tumor associated macrophages as key contributors and targets in current and future therapies for melanoma.

Habib S and 15 others. Expert Rev Clin Immunol, 2024. Cited by 22 papers, by iCite.

Cite this record

ConductScience Library. Tumor associated macrophages as key contributors and targets in current and future therapies for melanoma. Papers, record 38533720. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38533720

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tumor associated macrophages as key contributors and targets in current and future therapies for melanoma.
PubMed
Journal
Expert Rev Clin Immunol
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
22
iCite
Relative citation ratio, by iCite
3.08, provisional
iCite
Revised in PubMed
2026-07-08
PubMed

Authors16

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Habib SShabana
2Osborn GGabriel
3Willsmore ZZena
4Chew MWMin Waye
5Jakubow SSophie
6Fitzpatrick AAmanda
7Wu YYin
8Sinha KKhushboo
9Lloyd-Hughes HHawys
10Geh JLCJenny L C
11MacKenzie-Ross ADAlastair Dhttps://orcid.org/0000-0001-7299-8656
12Whittaker SSean
13Sanz-Moreno VVictoria
14Lacy KEKatie E
15Karagiannis SNSophia N
16Adams RRebecca

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MelanomaMajor topic
Tumor MicroenvironmentMajor topic
ImmunotherapyMajor topic
Tumor-Associated MacrophagesMajor topic
Humans
Animals
Molecular Targeted Therapy
Clinical Trials as Topic
Macrophages

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Wellcome TrustUnited KingdomPubMed
MR/V049445/1Medical Research CouncilUnited KingdomPubMed

Source PubMed

Download CSV of grants

References157

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133228719Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients.J Transl Med2020https://conductscience.org/library/papers/33228719PubMed
235363544Human dendritic cells in cancer.Sci Immunol2022https://conductscience.org/library/papers/35363544PubMed
333161320Breast cancer cells and macrophages in a paracrine-juxtacrine loop.Biomaterials2021https://conductscience.org/library/papers/33161320PubMed
428272106M1 and M2 macrophages' clinicopathological significance in cutaneous melanoma.Melanoma Res2017https://conductscience.org/library/papers/28272106PubMed
526526369TGF-β-Induced Transcription Sustains Amoeboid Melanoma Migration and Dissemination.Curr Biol2015https://conductscience.org/library/papers/26526369PubMed
626089604Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms.Mediators Inflamm2015https://conductscience.org/library/papers/26089604PubMed
736497391Adrenomedullin Secreted by Melanoma Cells Promotes Melanoma Tumor Growth through Angiogenesis and Lymphangiogenesis.Cancers (Basel)2022https://conductscience.org/library/papers/36497391PubMed
833457097Generation of GM-CSF-producing antigen-presenting cells that induce a cytotoxic T cell-mediated antitumor response.Oncoimmunology2020https://conductscience.org/library/papers/33457097PubMed
928423340Transforming Growth Factor-β Signaling in Regulatory T Cells Controls T Helper-17 Cells and Tissue-Specific Immune Responses.Immunity2017https://conductscience.org/library/papers/28423340PubMed
1028473638Mapping the human DC lineage through the integration of high-dimensional techniques.Science2017https://conductscience.org/library/papers/28473638PubMed
1128514441PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity.Nature2017https://conductscience.org/library/papers/28514441PubMed
1235879449The complex role of tumor-infiltrating macrophages.Nat Immunol2022https://conductscience.org/library/papers/35879449PubMed
1325082815CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models.Cancer Res2014https://conductscience.org/library/papers/25082815PubMed
1431166680Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma.N Engl J Med2019https://conductscience.org/library/papers/31166680PubMed
1537215144The transcriptional control of the VEGFA-VEGFR1 (FLT1) axis in alternatively polarized murine and human macrophages.Front Immunol2023https://conductscience.org/library/papers/37215144PubMed
1635195495BRAF inhibitors and their immunological effects in malignant melanoma.Expert Rev Clin Immunol2022https://conductscience.org/library/papers/35195495PubMed
1732733446Antigen Cross-Presentation by Macrophages.Front Immunol2020https://conductscience.org/library/papers/32733446PubMed
1826896096IFNγ and CCL2 Cooperate to Redirect Tumor-Infiltrating Monocytes to Degrade Fibrosis and Enhance Chemotherapy Efficacy in Pancreatic Carcinoma.Cancer Discov2016https://conductscience.org/library/papers/26896096PubMed
1936166727Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134.J Clin Oncol2023https://conductscience.org/library/papers/36166727PubMed
2035351601Macrophage inhibitory cytokine-1 in cancer: Beyond the cellular phenotype.Cancer Lett2022https://conductscience.org/library/papers/35351601PubMed

See all 157 referencesDownload CSV of references

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.

PMIDTitleJournalYearIn PapersSource
42938860Reprogramming the Melanoma Tumor Microenvironment: From Cellular Crosstalk to Cellular Immunotherapy.Cancers (Basel)2026https://conductscience.org/library/papers/42938860PubMed
42899013Innate immune cells in tumor immunity: dual roles, mechanistic insights, and therapeutic opportunities.Front Immunol2026https://conductscience.org/library/papers/42899013PubMed
42738348Rethinking Immunotherapy Resistance in Melanoma: A Narrative Review of Clinical Patterns, Resistance Mechanisms, and Future Strategies.Cancers (Basel)2026https://conductscience.org/library/papers/42738348PubMed
42311672Melanoma stem cells drive macrophage reprogramming to a hybrid phenotype, modulating melanoma stemness and compromising NK cell-mediated immunity.Front Immunol2026https://conductscience.org/library/papers/42311672PubMed
42197424Listeria monocytogenes-Derived Membrane Vesicles Suppress Melanoma Growth via Macrophage Activation Involving NF-κB Signaling.Microorganisms2026https://conductscience.org/library/papers/42197424PubMed
42193884Beyond Hematology-Current Insights into Chimeric Antigen Receptor (CAR) T-Cell Therapy for Skin and Connective Tissue Disorders.Cells2026https://conductscience.org/library/papers/42193884PubMed
42166711CSF1R-dependent CD169-positive macrophages locally constrain melanoma growth in the skin.J Exp Med2026https://conductscience.org/library/papers/42166711PubMed
42129932The role of galectins in modulating the tumor microenvironment and driving metastasis in skin cancers.Biol Res2026https://conductscience.org/library/papers/42129932PubMed
41872159Melanoma exosomal miR-708-5p promotes macrophage M2 polarization and cancer metastasis.Cell Death Dis2026https://conductscience.org/library/papers/41872159PubMed
41799379Mechanisms and Therapeutic Strategies to Overcome Immune Checkpoint Inhibitor Resistance in Melanoma, Head and Neck, and Triple-Negative Breast Cancers.J Cell Immunol2025https://conductscience.org/library/papers/41799379PubMed
41419864Melanoma treatment in the era of nanotechnology and precision medicine.J Nanobiotechnology2025https://conductscience.org/library/papers/41419864PubMed
41112239Emerging macrophage-based therapies for cancer: a review of preclinical and clinical advances.Front Immunol2025https://conductscience.org/library/papers/41112239PubMed
40993759Engineering macrophages for targeted immunotherapy and drug delivery in melanoma.J Transl Med2025https://conductscience.org/library/papers/40993759PubMed
40595758Unraveling the role of HIF2α in melanoma progression and epithelial-mesenchymal transition.Sci Rep2025https://conductscience.org/library/papers/40595758PubMed
40573249Metabolic Reprogramming in Melanoma: An Epigenetic Point of View.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/40573249PubMed
40399946Double-sided niche regulation in skin stem cell and cancer: mechanisms and clinical applications.Mol Cancer2025https://conductscience.org/library/papers/40399946PubMed
40180895Exploring the potential of selective FKBP51 inhibitors on melanoma: an investigation of their in vitro and in vivo effects.Cell Death Discov2025https://conductscience.org/library/papers/40180895PubMed
39769450Therapeutic Significance of NLRP3 Inflammasome in Cancer: Friend or Foe?Int J Mol Sci2024https://conductscience.org/library/papers/39769450PubMed
39619202The effects of plasma from patients with active thyroid-associated orbitopathy on the survival and inflammation of melanoma-associated fibroblasts.PeerJ2024https://conductscience.org/library/papers/39619202PubMed
39269597Focal adhesion kinase-mediated interaction between tumor and immune cells in the tumor microenvironment: implications for cancer-associated therapies and tumor progression.Clin Transl Oncol2025https://conductscience.org/library/papers/39269597PubMed

See all 21 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38533720

GET https://conductscience.org/api/papers/v1/38533720/references?page=2